Abbott Diet Pill to Face Tougher Warnings from European Drug Agency

.

Abbott Diet Pill to Face Tougher Warnings from European Drug Agency

European regulatory authorities on Thursday said an Abbott Laboratories (ABT) diet pill should be banned from sale in the market, issuing tougher warnings for the drug because the drug poses high risks of stroke and heart attack.

The warning was conveyed after a study of 10,000 patients suggested it put them at a higher risk for heart disease.

The study revealed 11.4% of those who used Meridia as a medication faced a cardiovascular event such as a heart attack, compared with 10% of patients who received a fake pill.

This medicine is sold in Europe under the brand-names Reductil, Reduxade, Zelium and other names; and as Meridia in the U. S.

The warning for not to use Meridia is to include patients with a history of problems as Coronary artery disease, heart attack, transient ischemic attack, Arrhythmia, Congestive heart failure, Peripheral arterial disease, uncontrolled hypertension.

The agency's decision will now get passed to the European Commission for review.

The FDA said Abbott has agreed to update the label bearing “recommended the drug shouldn't be used in patients with a history of heart disease, “and further plans to convene an advisory committee meeting to further discuss the safety and risks with Meridia.


Latest News

Herb Strather, Detroit blight Buyer Makes a Wednesday Deadline
Baidu with its Growing Mobile Presence, Hit 27 Percent Profit Increase
Third Quarter Profits for Samsung Electronics Drop Sharply
Federal Reserve Ends Bond Buying Programme, Keeps Interest Rates Low
Reduced Growth in Major Overseas Economies Affect U.S. Durable Goods Order
Lowe’s to Introduce Robots in Store for Customer Service
Facebook Shares Fall as the Company Portrays Increased in Expenses in 2015
USPS Audit Questions the Consistency of Surveillance Conducted on Mail
For the CEO of Twitter, Growth in Number of Users Is the First Priority
Highest Retail Sales Noted in Japan in Last Four Months
Madison Square Garden Co. is Planning a Split in Its Media, Sports and Entertain
In Matters of Auto Reliability Detroit Automakers Trail Behind Foreign Companies